JMIR Publications

ABSTRACT

Background:

The clinical activities developed by pharmacists in a hospital environment can improve health outcomes and generate savings for hospitals. However, to determine whether pharmaceutical interventions are cost-effective, it is essential to define a method according to which cost-effectiveness is intended to be measured. In addition, the quality of economic assessments and the amount of information present in systematic reviews in the literature make it difficult to analyse the effects of this intervention.

Objective:

Provir an overview of systematic reviews on the pharmacoeconomic impact of the performance of clinical pharmacists in hospitals

Methods:

A systematic search of the Cochrane Library databases, PubMed/MEDLINE, LILACS, Scopus, Web of Science, Google Scholar, and Open Thesis will be performed using the PRISMA statement. The search will involve the use of keywords determined using the Medical Subject Headings (MeSH) database to define the search terms and include the following terms: ‘pharmacoeconomics’, ‘clinical pharmacy services’, and ‘hospital’. The study designs to be included will be systematic reviews of good quality. The primary result will be the ratio of cost, in monetary units, to the outcome, in monetary units or natural units. The secondary economic results will be determined based on factors associated with drugs and translated into benefit, effectiveness, or usefulness.

Results:

Overview not started, starting in February 2022. This protocol was previously approved by PROSPERO under number CRD420191406665.

Conclusions:

Ethics and dissemination. The review will be performed under Master's research approved by the Ethics Committee of the University Hospital of the Federal University of Sergipe. The results will be submitted to indexed journals and national and international meetings. Clinical Trial: PROSPERO CRD420191406665.